|
Market Closed -
Nasdaq
23:00:00 18/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7000 USD | +4.14% |
|
-39.13% | -55.70% |
| 08-17 | EyePoint's drug for age-related eye disease fails late-stage trial, shares tank | RE |
| 08-17 | Outlook Therapeutics Insider Bought Shares Worth $2,499,999, According to a Recent SEC Filing | MT |
Stock exchange
Nasdaq
OTLK 0.7000 $
+4.14%
28.53M
$
Quotes 5-day view: Outlook Therapeutics, Inc.
Delayed Quote Nasdaq| 12/08/2026 | 13/08/2026 | 14/08/2026 | 17/08/2026 | 18/08/2026 | |
|---|---|---|---|---|---|
| Last | $1.100 | $0.8888 | $0.7564 | $0.6722 | $0.7000 |
| Volume | 8,070,070 | 82,392,948 | 104,623,239 | 80,658,264 | 40,686,451 |
| Change | -2.65% | -19.20% | -14.90% | -11.13% | +4.14% |
| Opening | $1.120 | $0.7690 | $0.8438 | $0.7954 | $0.6722 |
| High | $1.180 | $0.8918 | $0.8438 | $0.7975 | $0.7039 |
| Low | $1.070 | $0.7602 | $0.7120 | $0.6700 | $0.6020 |
Performance
| 1 day | +4.14% | ||
| 1 week | -39.13% | ||
| Current month | -28.32% | ||
| 1 month | -49.64% | ||
| 3 months | +206.88% | ||
| 6 months | +65.76% | ||
| Current year | -55.70% | ||
| 1 year | -70.09% | ||
| 3 years | -97.54% | ||
| 5 years | -98.47% | ||
| 10 years | -99.88% |
Volumes
marketsDaily volume
40,750,931
Estimated daily volume
40,750,931
Avg. Volume 20 sessions
24,510,112
Daily volume ratio
1.66
Avg. Volume 20 sessions USD
17,157,078.4
Record volume 1
346,266,295
Record volume 2
107,389,755
Record volume 3
104,623,239
Capital turnover ratio
0.13
Float rotation
0.16
Basic data
Market Cap (USD)
125,699,382
Net sales (USD)
1,413,000
Number of employees
17
Sales / Employee (USD)
83,118
Free-Float
64.23 %
Free-Float capitalization (USD)
104,773,115
Average Daily Capital Traded
13.65%
Indicators
Moving average 5 days
0.9095
Moving average 20 days
1.089
Moving average 50 days
1.284
Moving average 100 days
0.8036
Price spread / (MMA5)
+29.93%
Price spread / (MMA20)
+55.51%
Price spread / (MMA50)
+83.37%
Price spread / (MMA100)
+14.80%
STIM
RSI 9 days
29.39
RSI 14 days
34.6
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.14% | -39.13% | -70.09% | -97.54% | 126M | ||
| -0.11% | -2.38% | +2.06% | +19.57% | 48.84B | ||
| +1.89% | +4.36% | +494.71% | +637.45% | 45.44B | ||
| +1.83% | +2.83% | +14.87% | +91.99% | 41.22B | ||
| -0.50% | -0.81% | +25.61% | +12.05% | 39.71B | ||
| -2.74% | -2.74% | +17.30% | +56.10% | 32.6B | ||
| +0.59% | -2.65% | - | - | 16.25B | ||
| -1.14% | -2.01% | +28.93% | +132.78% | 16.67B | ||
| -0.49% | -0.54% | +2.96% | +27.12% | 14.08B | ||
| -2.60% | +0.79% | +78.19% | +39.69% | 13.68B | ||
| Average | +0.09% | -4.85% | +66.06% | +102.13% | 26.86B | |
| Weighted average by Cap. | -0.02% | -0.86% | +104.45% | +155.12% |
Historical Quotes: Outlook Therapeutics, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
77a85abbe2c18dc.ruNl2qKNmeloMtEWlT6AuaTm01cQ1-DImOW6PdTguI0.669c6-DrzI8tXrRFo2G01uLVshFE7quwr6jMZbOz3_SDpT25j_zOhzBlhA
| Date | Price | Volume | Total |
|---|---|---|---|
| 23:00:00 | 0.7000 | 59,448 | 39,957,780 |
| 22:59:59 | 0.7029 | 100 | 39,898,332 |
| 22:59:59 | 0.7030 | 100 | 39,898,232 |
| 22:59:59 | 0.7029 | 100 | 39,898,132 |
| 22:59:59 | 0.7029 | 100 | 39,898,032 |
| 22:59:59 | 0.7030 | 100 | 39,897,932 |
| 22:59:57 | 0.7030 | 100 | 39,897,832 |
| 22:59:56 | 0.7030 | 233 | 39,897,732 |
| 22:59:56 | 0.7029 | 100 | 39,897,499 |
| 22:59:56 | 0.7029 | 100 | 39,897,399 |
Course Extremes
| 1 week | 0.6 | 1.18 | |
| 1 month | 0.6 | 1.75 | |
| Current year | 0.16 | 1.88 | |
| 1 year | 0.16 | 3.39 | |
| 3 years | 0.16 | 29.2 | |
| 5 years | 0.16 | 57.3 | |
| 10 years | 0.16 | 878.4 |
Monthly variations
Annual variations
| 2026 | -55.70% | ||
| 2025 | -16.40% | ||
| 2024 | -76.02% | ||
| 2023 | -63.52% | ||
| 2022 | -20.59% | ||
| 2021 | +4.62% | ||
| 2020 | +120.34% | ||
| 2019 | -85.25% | ||
| 2018 | -61.54% | ||
| 2017 | -56.81% | ||
| 2016 | -29.51% |
- Stock Market
- Stocks
- OTLK Stock
- Quotes Outlook Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















